MarketCap
Facebook
X
Telegram
C4 Therapeutics DSO Ratio | CCCC
Annual DSO Ratio C4 Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.9 | 76.4 | 117 | 42.2 | 40.7 | 49.3 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 | 27.9 | 58.9 |
Quarterly DSO Ratio C4 Therapeutics
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.8 | 29 | 39.2 | 37 | 35.4 | 71.9 | 70.2 | - | 34.2 | 56.1 | 381 | - | 6.3 | 195 | 35.1 | 47.3 | 10.1 | 5.85 | 44.6 | 24 | 59.4 | 46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 381 | 5.85 | 62.1 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agenus
AGEN
|
3.58 | $ 7.24 | 3.06 % | $ 215 M |  USA |
 |
AbCellera Biologics
ABCL
|
173 | $ 12.15 | -2.53 % | $ 3.63 B |  Canada |
 |
Aptevo Therapeutics
APVO
|
79 | $ 0.77 | -28.31 % | $ 243 K | USA |
 |
Aclaris Therapeutics
ACRS
|
7.42 | $ 4.35 | 4.82 % | $ 533 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
60.7 | $ 29.93 | 1.94 % | $ 4.54 B | USA |
 |
Biofrontera AG
BFRA
|
42.2 | - | -8.24 % | $ 105 M |  Germany |
 |
Capricor Therapeutics
CAPR
|
31.9 | $ 11.21 | 26.38 % | $ 521 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 28.59 | -1.62 % | $ 1.34 B | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
106 | - | 1.68 % | $ 4.65 B |  China |
 |
Aquestive Therapeutics
AQST
|
103 | $ 3.59 | 1.85 % | $ 384 M | USA |
 |
Jaguar Health
JAGX
|
48.3 | $ 0.48 | 10.08 % | $ 1.12 M | USA |
 |
Arvinas
ARVN
|
4.66 | $ 6.92 | -0.36 % | $ 491 M | USA |
 |
Cerus Corporation
CERS
|
47 | $ 2.12 | 8.46 % | $ 404 M | USA |
 |
Pulmatrix
PULM
|
21.7 | $ 1.31 | -2.96 % | $ 4.78 B | USA |
 |
Fortress Biotech
FBIO
|
115 | $ 2.02 | 5.65 % | $ 56.4 M | USA |
 |
Inhibrx
INBX
|
24.6 | $ 90.76 | 0.17 % | $ 4.28 B | USA |
 |
Entera Bio Ltd.
ENTX
|
548 | $ 3.21 | -0.9 % | $ 148 M |  Israel |
 |
Flexion Therapeutics, Inc.
FLXN
|
129 | - | - | $ 459 M | USA |
 |
Legend Biotech Corporation
LEGN
|
3.53 K | $ 19.66 | -3.7 % | $ 7.25 B | USA |
 |
CytomX Therapeutics
CTMX
|
12.3 | $ 2.15 | 8.59 % | $ 297 M | USA |
 |
Krystal Biotech
KRYS
|
109 | $ 310.6 | 1.34 % | $ 8.99 B | USA |
 |
Kura Oncology
KURA
|
29.4 | $ 7.74 | 2.18 % | $ 679 M | USA |
 |
Inhibikase Therapeutics
IKT
|
27.9 | $ 1.64 | 5.48 % | $ 161 M | USA |
 |
Heron Therapeutics
HRTX
|
198 | $ 0.36 | -3.39 % | $ 60 M | USA |
 |
Inovio Pharmaceuticals
INO
|
3.35 K | $ 1.44 | -1.03 % | $ 67.5 M | USA |
 |
Aytu BioScience
AYTU
|
171 | $ 1.83 | 0.83 % | $ 22.5 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
21.9 | - | -5.76 % | $ 99.8 M | USA |
 |
Innoviva
INVA
|
24.6 | $ 18.87 | -1.1 % | $ 1.27 B | USA |
 |
BioCardia
BCDA
|
198 | $ 0.94 | 0.9 % | $ 6.27 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
5.4 | - | 0.11 % | $ 419 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 2.28 | -1.72 % | $ 14.6 B |  Australia |
 |
Shineco, Inc.
TYHT
|
172 | - | -3.90 % | $ 97.2 M | China |
 |
Certara
CERT
|
89.6 | $ 11.73 | -3.3 % | $ 1.88 B | USA |
 |
Dyadic International
DYAI
|
78.4 | $ 0.38 | 3.5 % | $ 13.8 M | USA |
 |
Anika Therapeutics
ANIK
|
76.5 | $ 13.91 | 3.27 % | $ 199 M | USA |